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Abstract
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inhibited the adenovirus·12 onocogenesis. Membrane immunofluorescent test, however, failed to
demonstrate the fetal antigens in any of adnovirus-12-induced tumor cells, SV40induced tumor
cells and cells from spontaneous hamster lymphoma.
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Abstract: The effect of immunization with hamster fetal cells on
the tumor induction by adnovirus type 12 was studied by in vivo and
in vitro. The immunization with lO-day old fetal cells showed a recog-
nizable inhibition on the tumor induction by adenovirus type 12. The
inhibition was observed only in males but not in females. For the
inhibition, immnization with 107 or more cells was required. The
immunization with same dose of l2-day-old fetal cells were ineffective.
The inoculation of the spleen cells from hamsters immunized with un·
irradiated fetal cells strongly inhibited the adenovirus·12 onocogenesis.
Membrane immunofluorescent test, however, failed to demonstrate
the fetal antigens in any of adnovirus-12-induced tumor cells, SV40-
induced tumor cells and cells from spontaneous hamster lymphoma.
Evidence has been accumulating in the literature that fetal cells have
antigens that cross-react with specific antigens in tumor cells (I, 2, 3). Among
these fetal antigens, transplantation type antigens are particularly interesting,
because, if they really exist, the immunization with fetal tissues might be
very useful for the immunotherapy of cancers. Recently CoGGIN et ai. have
reported that immunization of adult hamsters with irradiated fetal hamster or
mouse cells produced strong immunity to the challenge by SV40·induced
tumor cells and simultaneously induced cytostatic antibody formation (4).
From these experimental results and the suggestion that only a limited
number of proteins could be coded for by the viral genome (5), they postulated
that during the process of oncogenesis there is a derepression of fetal genes,
resulting in the de novo synthesis of antigenic substances detectable as trans-
plantation antigens of tumors. They also postulated that fetal antigens might
be the same as tumor-specific transplantation antigens (TSTAs) of SV40-
tumors and, probably of many other tumors. Why do similar or identical
antigens appear in tumor cells of different species transformed by the same
virus of which viral genes do not code for TSTA, and how could we explain
the peculiar fact that immunization with mid·gestation hamster fetal cells
could confer the resistance to various tumors induced by different oncogenic
viruses (4,6, 7)? As for these questions, CoGGIN et al. explained that, just as
the early events of embryogenesis are morphologically almost identical in all
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vertebrates, the molecular requirements are also very similar; thus TSTAs
induced by the same virus are identical regardless of animal species. Their
report on the inhibition of SV 40 tumorigenesis in hamsters by immunization
with human fetal tissue homogenates would support the supposition (8).
The cross-reactivity between the TSTAs of tumors induced by the highly
oncogenic group A and the weakly oncogenic group B adenovirus types has
been reported (9). Nucleic acid hybridization experiments, however, de-
monstrated that the complementarity is specific for both DNA of the in·
ducing virus type and other types belonging to the same adnovirus group (10).
These findings suggest that the TSTAs found to be common to tumors in-
duced by adenoviruses of groups A and B would not be coded for by the
virus but their appearance would rather be due to the derepression of the
fetal genes or other cellular genes. Thus, the genetic background of TSTAs
of adenovirus tumors is still obscure, and the reports on the fetal antigens or
their relationship with TSTAs in adenovirus tumors are very limited (7).
As the first step to study the existence and the characteristics of fetal antigens
in adenovirus tumors, the author investigated the effect of immunization with
hamster fetal cells on adenovirus-12 (Ad-12) oncogenesis.
MATERIALS AND METHODS
Animals: Experiments were carried out with our closed colony of randomly
mated Syrian hamsters (Mesocricetus auratus) (11). Within 24 hours after birth,
O. 1 ml of virus was injected into the dorsal subcutaneous tissue of newborn
hamsters. Immunizations with embryonic tissue were performed at 18 days of
age by intraperitoneal injection. At three weeks of age the hamsters were
weaned and segregated according to sex. All animals were examined three
times a week for tumors until five months of age, when the experiments were
terminated. In each experiment, nonimmnized animals and animals immunized
with adult kidney cells were included as controls.
Virus: Adnovirus type 12 (Huie) was cultured in HeLa cells. The cultures
were harvested when cytopatic effect was maximum by three cycles of
freezing and thawing. The cell debris was removed by low speed centrifuga-
tion and the supernatant was used for experiments. The virus titer was deter-
mined in HeLa cells as described by YABE et al. (12). The virus used in the
present studies contained lOZ 0-2.5 tissue culture infective doses (TOlD 50/0. lml).
Preparation of Fetal Cells: Primiparous mothers were used to obtain
embryos, since it has been reported that there was no significant delay in SV40
tumorigenesis in hamsters immunized with fetal tissue from multiparous fema-
les (13). Generally a male hamster was placed in a box containing one virgin
female in the late evening. Females were observed daily early in the morning
for sperms in the vaginal smear. The day of detection of sperms in mated
females was taken as day 0 of embryo development, and the approximate age
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of the embryo was calculated accordingly. Pregnant hamsters were killed, and
the embryos were removed from the uterine sacs and soaked in cold Hank's
balanced salt solution (HBSS). The fetuses were aspirated gently through 21-
gauge needles into a lO-ml syringe. The preparations of dispersed embryos
were further drawn through a 23·gauge needles and transferred into a large
centrifuge tube containing cold HBSS to spin down at 500 rpm for five min.
x-irradiation was performed in plastic tubes at a distance of 45 cm from the
source of the Toshiba KXL-19 x·ray machine equipped with 0.5 mm alminum
and 0.5 mm copper filters. The unit was set at 200 kVp, 25 mA, delivering
213 R/min for 23 min 27 sec to perform 5OOO.R irradiation. Viable cells were
counted after irradiation by use of the trypan blue dye exclusion test. The
unstained cells usually constituted 25 to 30% of the total. The cell concentra·
tion was adjusted by further dilution with HBSS.
Kidney Cells: Retired male breeders were perfused gently with warm
phosphate·buffered saline (PBS, through the left ventricle until the kidney
became grossly white, then the kidneys were removed, trimmed and washed
in HBSS. After thorough mincing under aspetic conditions, the cells were
suspended in HBSS and passed gently through a sterile Teflon homogenizer to
obtain disaggregated cells. The procedures for viable cell count and x·irradia-
tion were similar to those used for the preparation of embryo cells.
Tumor Cells: Hamsters bearing Ad·12 tumors were killed by cranial dis-
location and tumors were removed aseptically. Tumor cell suspension was
prepared in the same way as the kidney cell suspension except for perfusion
with PBS.
Spieen Cells: Two-month old male hamsters were immunized with irra·
diated or unirradiated 1X 107 hamster fetal cells. Animals were killed by
dislocation of cervical spine, usually 11 days after immunization. Spleens were
dissected free of the surrounding tissue under aspectic conditions, placed in a
small amount of medium 199 in a loose-fitting Teflon homogenizer and gently
ground by hand. The suspensions were allowed to stand in a refrigerator for
one hour. The supernatant was collected and washed with medium 199 and
then resuspended in the same fluid. Further purification of lymphocytes was
not done, since HEWETSON et ai. reported that the purified lymphocytes did not
show any greater inhibitory activity as did comparable leukocyte samples (14).
Cell Lines: Three lines of tissue culture cells were used in the membrane
immunofluorescent test. HT.4, Ad-12 transformed hamster cell line (15), and
HT, SV40 induced hamster tumor cell line, were supplied by Dr. C. HAMADA,
Kyoto University and Dr. aDA of our Medical School. These cells were grown
in Eagle's minimum essential medium IMEM) containing 10% heated fetal calf
serum (BDH Chemicals, England). They were previously shown to contain
Ad-12 S antigen (16) and SV40 S antigen (17). MLP.l cells, originated from
ascites of a hamster bearing transplantable spontaneous hamster lymphoma of
our laboratory (11), were grown as suspension in the medium RPMI 1640 con-
taining 15% heated fetal calf serum (18).
Antisera: Four. to five·week-old Syrian hamsters were immunized by eight
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intraperitoneal Injections with 2x 107 viable, x-irradiated and lO-day fetal
cells. Another six kinds of antisera were produced in the hamster and the
procedures of immunization were listed in Table 4. Sera were collected two
weeks after the last injection by cardiac puncture and kept at -80°C. All sera
were inactivated at 56°C for 30 minutes befor use.
Antisera and conjugates were routinely absorbed prior to use with an
equal volume of packed homogenated lung, liver, kidney and spleen of ham-
sters or 100 mg of hamster liver powder for one hr at 37°C. Two times of
absorptions were sufficient to reduce the non-specific staining.
Immunofluorescent Staining: Live cells were stained in suspension or
directly on monolayer by a modification of the method of MOLLER (19). Cells
were washed once with PBS and incubated with 0.1 m1 of undiluted antiserum
for one hr at 37°C. The cells were then washed three times with PBS and
incubated with O. 1 m1 of 1: 10 dilution of rabbit anti-hamster globulin con-
TABLE 1 EFFECT OF IMMUNIZATION WITH X-IRRADIATED
Immunogen Experimental group
Cells Dose Sex Tumor incidence Average(%) latent period!)
10 D. G. 2> 1 X 107 6 6/14 (42.8) 51. 3 days
Fetal cells ~ 8/8 (100) 40.3
10 D.G. 1 X 107 6 16/22 (72.8) 63.9
Fetal cells ~ N.D.3l
10 D.G. 1. 2x 106 6 20/20 (l00) 40.6
Fetal cells ~ 17/19 (89.5) 34.4
10 D.G. 3x 106 6 10/14 (71.4) 41. 5
Fetal cells ~ 14/16 (87.5) 44.3
12 D.G. 1 X 107 6 12/12 (l00) 51. 3
Fetal cells ~ 10/10 (l00) 39.0
Adult 1 X 107 6 15/19 (79.0) 58.0
kidney cells ~ 15/15 (l00) 48.3
Adenovirus- 1 X 107 6 9/15 (60.0) 53.5
12 tumor cells ~ N.D.
1) Average days from virus inoculation to appearance of palpable tumors.
2) D. G., days of gestation.
jugated with fluorescein isocynate (Miles laboratories, Kankakee). After three
washings with PBS, cells were suspended in a minimal volume of grycero1-PBS
mixture (1: 1), and mounted on a glass slide. Examination was done for
circumferential staining of cells by darkground ultraviolet fluorescence micro-
scopy with a colorless barrier filter.
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RESULTS
1. Effect of X-irradiated Fetal Cell Immunization
The influence of fetal cell immunization on Ad-12 oncogenesis was ex-
plored by comparing the tumor incidence and the incubation period for tumor
development among immunized and non-immunized hamsters. As shown in
Table 1 and Figure 1, duplicated experiments with 1 X 107 x-irradiated
lO-day fetal cells showed a slight reduction in tumor incidence (15.5 and
7.2%) and remarkable delay in tumor appearance (9.9 and 24.9 days) in male
hamsters. In females, however, no response to immunization was observed.
Hereafter, unless otherwise stated, the comparison between the experimental
group and the control group is done in males. The possibility of non-specfic
response of hosts was excluded by experiments using immunization with adult
FETAL CELLS ON ADENOVIRUS-12 TUMORIGENESIS
Control group
% Reduction of
Sex Tumor incidence Average tumor incidence(%) latent period
6 14/24 (58.3) 41. 4 days 15.5
.): 10/13 (76.9) 46.1 -23.3
6 12/15 (80.0) 39.0 7.2
.): 15/15 (100) 39.8
6 16/16 (100) 40.6 0
.): JO/I0 (100) 39.6 10.5
6 15/20 (75.0) 52.0 3.6
.): 22/22 (100) 49.1 12.5
6 12/15 (80.0) 39.0 -20.0
.): 15/15 (l00) 39.8 0
6 6/12 (50.5) 51. 9 -28.5
.): 11/12 (91.8) 41. 0 - 8.2
6 11/12 (91. 81 48.9 31. 8
.): 16/16 (100) 36.9
3) N.D., not done.
kidney cells (Table 1). In the experiments with smaller cell doses, there was
no detectable effect of immunization.
2. Effect ofUnirradiated Fetal Cells
Experiments with unirradiated fetal cells done In triplicate showed
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Fig. 1. The effect of immunization with hamster fetal cells
on the tumorigenesity of adenovirus-12 in male hamsters. The
virus was inoculated at birth and immunization was done once
at 17 days of age by single peritoneal injection of the fetal cells.
Broken line, control; Solid line with filled circles, animals im·
munized with irradiated cells; Solid line with open circles, animals
immunized with unirradiated cells.
TABLE 2 EFiECT OF IMMUNIZATION WITH U-,HRRADIATED
-------- _._------~-
Immunogen Experimental group
Cells Dose Sex Tumor incidence Average(%) latent period!)
IOD. G. 2) 1 X 107 6 8/16 (50.0) 66.0 days
Fetal cells ~ 20/20 (100) 36.4
10 D.G. 1X107 6 9/15 (60.0) 55.0
Fetal cells ~ 8/8 (l00) 50.1
10 D.G. 1X10
'
6 12/18 (66.7) 44. 7
Fetal cells ~ 8/8 (l00) 40.0
10 D.G. 1 X107 6 6/10 (60.0) 44.0
Fetal cells (X2)3) ~ 6/8 (75.0) 35.6
11 D.G. 1 X107 6 8/14 (57.1) 53.5
Fetal cells ~ 8/8 (100) 46.0
1) Average days from virus inoculation to appearance of palpable tumor
2) D. G., days of gestation
variable effects of immunization; 25 % and 13. 3% inhibition in the tumor
incidence in two experiments, and no effect in one experiment (Table 2). But
the latent period for tumor development was prolonged in all immunized
groups. Another group of hamsters were immunized twice with unirradiated
6
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fetal cells at a two-week interval. In this group, tumor incidence and the
latent period were the same as those of the group with a single immunization.
Almost all of the hamsters with tumors and all of the hamsters without
tumors had a large teratoma-like tumor. Microscopic examinations of these
artificially induced teratomas disclosed prominent cyst formation, nerve
tissue, hematopoietic tissue, hair follicles and sweat glands. This morpho-
logic appearance was similar to that reported by CooGIN et al. (7).
3. Age of Embryos and Immunizing Effect
The effect of immunization with unirradiated, II-days embryos appeared
to be slightly inferior to that obtained by immunization with lO·day embryos
(Table 2). The immunization with x-irradiated, 12-day embryos showed no
suppressive effect on the tumor development (Table 1).
4. Effut of Sensitized Spleen Cells
Since immune lymphocytes are primarily responsible for the rejection of
solid antigenic tumors and the presence of humoral cytotoxic antibodies seems
to be less important for their rejection, spleen cells from hamsters immunized
with fetal cells were tested in vivo for their inhibitory effect on Ad-12 onco-
genesis.
FETAL CELLS ON ADENOVIRUS-12 TUMORIGENESIS
Control group
% Reduction of
Sex Tumor incidence Average tumor incidence(%) latent period
6 15/20 (75.0) 52.4 25.0
~ 22/22 (100) 49.1 0
6 14/24 (58.3) 41. 4 - 1. 7
~ 10/13 (76.9) 46.1 -28.1
6 12/15 (80.0) 39.0 13.3
~ 15/15 (l00) 39.8 0
6 14/24 (58.3) 41. 4 - 1. 7
~ 10/13 (76.9) 46.1 1.9
6 15/20 (75.0) 52.4 17.9
~ 22/22 (100) 49.1 0
3) Immunized twice at two weeks' interval
In the first experiment, newborn hamsters were given subcutaneous in-
jection of the virus, and inoculation of the sensitized spleen cells was per-
formed on the 18th day. The results are summarized in Table 3. Injection
of spleen cells from hamsters immunized with unirradiated, lO-day fetal
cells reduced the tumor incidence in males (63.2%). The tumor incidence
7
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TABLE 3 EFFECT OF SENSITIZED SPLEEN
Experimental groupExp.
No.
Spleen cell donor
Sensitized with3 ) Dose
10 D. G. 5) Fetal 5x 107
cells (un-irradiated)
11 D. G. Fetal cells 5x 107
(un-irradiated)
10 D. G. Fetal cells 5x 107
(X-irradiated) X26 )
Normal adult spleen 5x 107
cells
10 D.G. Fetal cells 5x 107
(un-irradiated)
10 D. G. Fetal cells I X 107
(un-irradiated)
Sex Tumor incidence(%)
t 6/21 (28.6)
~ 18/18 (100)
"6 8/8 (100)
~ 10/10 (100)
"6 15/15 (100)
~ N.D.7)
"6 9/15 (60.0)
~ 7/7 (100)
"6 0/15 (0)
~ 0/10 (0)
"6 6/15 (40.0)
~ 14/18 (77. 8)
Average
latent period4 )
48.5 days
46.3
48.3
39.8
48.3
55. 7
43. 7
72.28 )
73.58 )
I) Spleen cells were inoculated intraperitoneally at 18 days of age into hamsters which
received adenovirus 12 at birth.
2) Spleen cells were inoculated intraperitoneally at II days of age into hamsters which
received adenovirus 12 at 7 days of age.
3) I X 107 viable cells were used for sensitization.
remained unchanged in female hamsters inoculated with the same dose of
sensitized spleen cells. Spleen cells from hamsters immunized twice with
x-irradiated, lO-day fetal cells or with un-irradiated ll-day fetal cells
showed no suppressive effects on Ad-12 tumor growth.
In the second experiment, the virus was given intraperitoneally to one
week-old hamsters and the spleen cells from the embryo-immunized hamsters
were injected intraperitoneally four days after virus inoculation. In this
case, no tumor developed not only in the male but also in the female ham-
sters when 5 X 107 sensitized spleen cells were inoculated into the recipients.
Inoculation of 1. 0 X 107 sensitized spleen cells also showed 30% reduction in
the tumor incidence.
As seen in the control hamsters in Table 3, sex difference was observed
in the tumor incidence among the hamsters receiving O. lml of Ad-12
within 24 hours after birth, whereas no sex difference was noted among the
hamsters receiving the same dose of the virus intraperitoneally one week
after birth.
5. Fetal Antigens on the Cell SurJace by Immunofluorescent Test
Sera from hamsters immunized with hamster fetal cells by seven dif-
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CELLS ON ADENOVIRUS-12 TUMORIGENESIS
Control group 0/0 Reduction of
Sex Tumor incidence Average tumor indicence(%) latent period
6 11/12 (91.8) 48.6 days 63.2
~ 16/16 (l00) 36. 7 0
6 11/12 (91.8) 48.6 8.2
~ 16/16 (l00) 36. 7 0
6 11/17 (64.7) 40.5 -35.3
~ 26/29 (89.7) 40. 7
6 11/17 (64.7) 40.5 4. 7
~ 26/29 (89.7) 40. 7 -10.3
6 14/20 (70.0) 68.28 ) 70.0
~ 16/21 (76.2) 73.58 ) 76.2
6 14/20 (70.0) 68.28 ) 30.0
~ 16/21 (76.2) 73.58 ) 1.6
4) Average days from virus inoculation to appearance of palpable tumors
5) D. G., days of gestation
6) Sensitized twice at 2-week interval
7) N. D., not done
8) Average days from virus inoculation to death by tumors.
ferent procedures were used for the detection of fetal antigens by membrane
immunofluorescent technique. As seen in Table 4, specific membrane fluo-
rescence was not observed in any of the tumor cells tested.
TABLE 4 ATTEMPT TO DETECT FETAL ANTIGENS BY MEMBRANE IMMUNOFLUORESCENT TECHNIQUE
Membrane immunofluorescenceAntisera Immunization procedure
HT·41 ) MLP-13)
Single immunization with 2 X 107 x-irradiated
lO-days fetal cells
2-3 Seven immunizations with 2 X 107 x-irradiated
lO-day fetal cells at one-week intervals
4-6 Eight immunizations with 2 X 107 x-irradiated
lO·day fetal cells at one-week intervals
8-10 Sera from pregnant hamsters at 10 days of
gestation on their second pregnancy
11-14 Sera from pregnant hamsters at 10 days of
gestation on their first pregnancy
16-18 Single immunization with 2 X 107 unirradiated
fetal cells into virgin hamsters
20-22 Single immunization with 2 X107 unirradiated
fetal cells and removal of resulting subcutaneous
embryoma
1) Adenovirus·12·transformed hamster cell line
3) Spontaneous hamster lymphoma cell line
2) SV40'induced hamster tumor cell line
9
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DISCUSSION
In the present experiments, immunization with fetal cells could confer
weak protection against the Ad-12 tumor growth. Injection of the spleen
cells from hamsters immunized with fetal cells also gave a strong inhibitory
effect on the Ad-12 oncogenesis. These results would mean the expression
of the fetal antigens on the surface of Ad-12 tumor cells.
For the inhibition of Ad-12 oncogenesis, the age of embryos used for
immunization was an important factor; lO-day fetal cells were effective,
but 12-day cells were not. This suggests that the fetal antigens which cross-
react with Ad-12 tumor cells disappear after this period in the embryo-
genesis. The age of embryos, which is effective for inhibition of tumors, is
12 days for SV40 (4), 14 days for polyoma virus (6), and 10 days for Ad-12.
This difference of the critical ages of embryo for effective immunogen would
suggest that different sets of fetal antigens might be expressed temporarily
during embryogenesis.
Large doses of fetal cells, 1 x 107 or more, must be used to obtain
enough immunity, and there was no detectable effect of immunization when
the cell doses injected were below 3 X 106 • Therefore, it is supposed that
fetal antigens on the membrane of fetal cells are not so dense as the normal
tissue antigens.
A marked sex difference was observed in the effect of fetal cells im-
munization in interrupting Ad-12 oncogenesis. In female hamsters, reduc-
tion of tumor incidence was obtained only when the virus was inoculated at
7 days of age and large doses of spleen cells (5 X 107 ) from embryo-immunized
hamsters were injected four days after the virus inoculation. Other proce-
dures of immunization could not influence the tumor incidence in female
hamsters. TING et al. claimed that the sex difference in the responsiveness
to the fetal cell immunization is one of the important characteristics of the
fetal antigens (20). In Ad·12 system, however, the tumor incidence itself is
also complicated by the sex of the hosts (21). The fact that the sex difference
of the tumor incidence in Ad-12 oncogenesis could be neutralized by thymec-
tomy at one week of age (22) or, as shown in the present study, by delay of
the virus inoculation to one week of age would suggest that the sex difference
of the tumor incidence is attributable to the sex-dependent difference of im-
munological maturity. It is likely, therefore, that the sex difference of the
effectiveness of fetal cell immunization in Ad·12 oncogenesis is due to the
difference in the numbers of the tumor cells developing in the recipients at
the time of immunization.
Various techniques in vitro have been applied to detect the surface antigens
10
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of the tumor and normal cells. Several authors demonstrated the surface
antigens of tumor ce1ls by membrane immunofluorescent test using the anti-
sera to tumor cells (23-25), and in some cases they also found the same
antigens in the fetal cells (24,25). On the contrary, TING et ala found
some difficulty in producing antisera to fetal antigens (20). Seven kinds of
immunization with fetal cells were performed in the present study, and the
resulting sera did not react with the the tumor cells tested. However, Ad-12
oncogenesis was inhibited by the adoptive transfer of spleen cells from ham-
sters immunized with fetal cells. Accordingly, these evidences indicate that
the fetal antigens may stimulate the production of cellular antibody rather
easily than that of humoral one.
The highly oncogenic group A adenoviruses and weakly oncogenic group
B adnoviruses all induce a common TSTA (9). Hamster fetal cells possess
a cross-reactive antigen to Ad-31 and Ad-12 hamster tumor cells as reported
by CoGGIN et ala (7) and as in the present study. These facts support the
postulation that fetal antigens might be the same as TSTA of tumors induced
by adnoviruses. On the other hand, it has been also reported that the TSTAs
of tumors induced by other than adnoviruses are virus-specific (26). The
antiserum to fetal tissue reacts with various tumor cells, but fetal tissue fails
to remove the reactivity of the antisera to tumor antigens (20). Furthermore,
anti-embryo sera react with SV40 "cryptic" transformants which contain SV40
genome but do not express its function, while the anti-SV40 tumor sera do
not react (27). From these facts, it can be assumed that viral neoplasms may
possess at least two types of transplantation antigens; one type may be coded
directly by the viruses and the other may be controlled by the function of
derepressed fetal genes.
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